Back to ANRO
MORGAN STANLEY ANRO Position History
Alto Neuroscience, Inc. • Healthcare
Quarters held
29
Latest value
$161K
Q3 2026
Peak value
$2.9M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $32 |
| Q3 2025 | $87K |
| Q3 2025 | $14K |
| Q3 2025 | $142K |
| Q3 2025 | $2K |
| Q4 2025 | $36 |
| Q4 2025 | $156K |
| Q4 2025 | $90K |
| Q4 2025 | $622K |
| Q4 2025 | $246K |
| Q4 2025 | $54K |
| Q1 2026 | $4K |
| Q1 2026 | $787 |
| Q1 2026 | $475K |
| Q1 2026 | $159K |
| Q1 2026 | $727K |
| Q1 2026 | $178K |
| Q2 2026 | $190K |
| Q2 2026 | $2K |
| Q2 2026 | $557K |
| Q2 2026 | $185K |
| Q2 2026 | $861K |
| Q2 2026 | $183K |
| Q3 2026 | $2.9M |
| Q3 2026 | $28K |
| Q3 2026 | $2.2M |
| Q3 2026 | $219K |
| Q3 2026 | $1.2M |
| Q3 2026 | $161K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $161K | 6.3K | — | — |
| Q3 2026 | $1.2M | 46.6K | — | — |
| Q3 2026 | $219K | 8.6K | — | — |
| Q3 2026 | $2.2M | 86.1K | — | — |
| Q3 2026 | $28K | 1.1K | — | — |
| Q3 2026 | $2.9M | 112.4K | — | — |
| Q2 2026 | $183K | 6.9K | — | — |
| Q2 2026 | $861K | 32.6K | — | — |
| Q2 2026 | $185K | 7.0K | — | — |
| Q2 2026 | $557K | 21.1K | — | — |
| Q2 2026 | $2K | 67 | — | — |
| Q2 2026 | $190K | 7.2K | — | — |
| Q1 2026 | $178K | 7.9K | — | — |
| Q1 2026 | $727K | 32.3K | — | — |
| Q1 2026 | $159K | 7.1K | — | — |
| Q1 2026 | $475K | 21.1K | — | — |
| Q1 2026 | $787 | 35 | — | — |
| Q1 2026 | $4K | 173 | — | — |
| Q4 2025 | $54K | 3.0K | — | — |
| Q4 2025 | $246K | 13.8K | — | — |
| Q4 2025 | $622K | 34.9K | — | — |
| Q4 2025 | $90K | 5.0K | — | — |
| Q4 2025 | $156K | 8.8K | — | — |
| Q4 2025 | $36 | 2 | — | — |
| Q3 2025 | $2K | 600 | — | — |
| Q3 2025 | $142K | 35.4K | — | — |
| Q3 2025 | $14K | 3.5K | — | — |
| Q3 2025 | $87K | 21.5K | — | — |
| Q3 2025 | $32 | 8 | — | — |
Other funds holding ANRO
$97.8M
$94.7M
$83.4M
$71.9M
$69.5M
$61.2M